A high CD34+ cell dose is associated with better disease-free survival in patients with low-risk diseases undergoing peripheral blood stem cell transplantation from HLA-matched related donors-Reference-Cited by-同舟云学术

A high CD34+ cell dose is associated with better disease-free survival in patients with low-risk diseases undergoing peripheral blood stem cell transplantation from HLA-matched related donors

Published:2020-02-10 Issue:9 Volume:55 Page:1726-1735
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Yokoyama Yasuhisa^ORCID,Maie Koichiro^ORCID,Fukuda Takahiro,Uchida Naoyuki,Mukae Junichi,Sawa Masashi,Kubo Kohmei,Kurokawa Mineo,Nakamae Hirohisa,Ichinohe Tatsuo,Atsuta Yoshiko,Chiba Shigeru

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-020-0817-5.pdf

Reference20 articles.

1. Yamamoto C, Ogawa H, Fukuda T, Igarashi A, Okumura H, Uchida N, et al. Impact of a low CD34(+) cell dose on allogeneic peripheral blood stem cell transplantation. Biol Blood Marrow Transpl. 2018;24:708–16.

2. Remberger M, Torlen J, Ringden O, Engstrom M, Watz E, Uhlin M, et al. Effect of total nucleated and CD34(+) cell dose on outcome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2015;21:889–93.

3. Zaucha JM, Gooley T, Bensinger WI, Heimfeld S, Chauncey TR, Zaucha R, et al. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood. 2001;98:3221–7.

4. Ringden O, Barrett AJ, Zhang MJ, Loberiza FR, Bolwell BJ, Cairo MS, et al. Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses. Br J Haematol. 2003;121:874–85.

5. Mohty M, Bilger K, Jourdan E, Kuentz M, Michallet M, Bourhis JH, et al. Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation. Leukemia. 2003;17:869–75.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of CD34⁺ cell dose on engraftment and long‐term outcomes after allogeneic bone marrow transplantation;Clinical Transplantation;2024-04

2. Impact of CD34 positive cell dose in donor graft on the outcomes after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide – A retrospective single-center study with a Japanese cohort;Blood Cells, Molecules, and Diseases;2024-03

3. Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery?;Leukemia;2023-07-20

4. Nomogram for Predicting Early Mortality after Umbilical Cord Blood Transplantation in Children with Inborn Errors of Immunity;Journal of Clinical Immunology;2023-05-08

5. Effect of graft cell dose on second transplantation from a haploidentical donor with post-transplantation cyclophosphamide for relapsed/refractory acute leukemia;Bone Marrow Transplantation;2023-04-28